What Does Elevated Troponin Mean in COVID-19?

Allan Jaffe

How to Recognize Inflammatory Illness? When to Refer to a Rheumatolo…

Cleveland Clinic Rheumatology and Immunology Series

A. Brown

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Cardio-Renal Syndrome Management: What Are the Key Factors That Impa…

Patricia Kao

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

APOL1 Controversies Conference Plenary: APOL1 Pathophysiology

KDIGO

D. Friedman

A New Paradigm: Rethinking Hypherphosphatemia Management

Icahn School of Medicine at Mount Sinai

D. Spiegel

Management and Treatment Decisions in Progressive Pulmonary Fibrosis

CHEST 2022 Coverage

T. Kulkarni

Update in the Understanding and Management of Lupus

ARTHROS

M. Petri

Ever-Evolving Lupus Case & Cytopenias in SLE

Cleveland Clinic Department of Allergy & Immunology

E. Littlejohn

Dermatologic Manifestations in Rheumatic Diseases

Saakshi Khattri

Social Determinants of Health for Cardiovascular Kidney Metabolic Sy…

Kibret Enyew Belay

KDIGO Scientific Symposium on the Impact of Viral Infection and the …

KDIGO

S. Chadban, U. Huynh-Do, M. Jadoul, D. Kumar

Cancer Before Solid Organ Transplant

Fred Hutchinson Cancer Center

C. Blosser

Health Disparities in SLE

Hospital for Special Surgery

J. Yazdany

EADV 2024 Insights: Calciphylaxis

EADV 2024 Insights

C. Erfurt-Berge

Interview with IgA Nephropathy Patient Alistair

Leicester IgA Nephropathy

L. Iga Nephropathy

Use of Cannibis in Rheumatology: What Are the Effects and Efficacy f…

USC Clinical Rheumatology Update: Focus on RA, Axial Spondylarthritis, Lupus, Soft Tissue Syndromes, Rheumatic Disorders

S. Metyas